Ingersoll Rand Reports Third Quarter 2025 Results
    
    
      
    
    
      Third Quarter 2025 Highlights
    
    
      (All comparisons against the third quarter of 2024 and results are as reported unless otherwise noted.)
    
    
      Strong performance driven by its competitive differentiator - Ingersoll Rand Execution Excellence (IRX):
    
    
      •Orders of $1,942 million, up 8%
    
    
      •Revenues of $1,955 million, up 5%
    
    
      •Net income attributable to Ingersoll Rand Inc. of $244 million, $0.61 per share
    
    
      ◦Adjusted net income1 of $346 million, $0.86 per share
    
    
      •Adjusted EBITDA1 of $545 million, up 2%, with a margin of 27.9%
    
    
      •Operating cash flow of $355 million and free cash flow1 of $326 million
    
    
      •Liquidity of $3.8 billion as of September 30, 2025, including $1.2 billion of cash on hand and undrawn capacity of $2.6 billion under available credit facilities
    
    
      
    
    
      DAVIDSON, N.C. - October 30, 2025 - Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, reported strong financial results for the third quarter 2025.
    
    
      "We delivered positive organic orders growth in the third quarter across both segments," said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. "Our performance demonstrates the resilience of our business, which combined with our strong balance sheet, enables durable long-term growth. We remain well positioned for future growth with our proven agile business model, operational excellence, and ownership mindset."
    
    
      Third Quarter 2025 Segment Review
    
    
      (All comparisons against the third quarter of 2024 and results are as reported unless otherwise noted.)
    
    
      Industrial Technologies and Services Segment (IT&S): Broad range of compressor, vacuum, blower, and air treatment solutions as well as industrial technologies including power tools and lifting equipment
    
    
      •Orders of $1,522 million, up 7%, or up 0.3% organic
    
    
      •Revenues of $1,541 million, up 5%, or down 2% organic1
    
    
      •Segment Adjusted EBITDA of $448 million, down 1%
    
    
      •Segment Adjusted EBITDA Margin of 29.0%, down 170 basis points
    
    
      •IT&S saw its third consecutive quarter of organic orders growth, with a book to bill of 0.99x, and a year to date book to bill of 1.04x. Adjusted EBITDA margin was down year over year, driven largely by the flow-through on organic volume declines, the dilutive impact of tariffs, and continued commercial investments for growth.
    
    
      Precision and Science Technologies Segment (P&ST): Mission-critical precision liquid, gas, air, and powder
    
    
      handling technologies for life sciences and industrial applications as well as aerospace and defense applications
    
    
      •Orders of $420 million, up 11%, or up 7% organic
    
    
      •Revenues of $415 million, up 5%, or up 2% organic1
    
    
      •Segment Adjusted EBITDA of $128 million, up 8%
    
    
      •Segment Adjusted EBITDA Margin of 30.8%, up 80 basis points
    
    
      
    
    
      1 Non-GAAP measure (definitions and/or reconciliations in tables below)
    
    
      1
    
    
    
      •P&ST delivered organic orders growth in both the Precision Technologies and Life Sciences businesses in the third quarter. Book to bill for the quarter was 1.01x and 1.02x year-to-date. Adjusted EBITDA margin continued to show improvement, up 130 basis points sequentially from the second quarter and up 80 basis points year over year.
    
    
      Balance Sheet and Cash Flow
    
    
      Ingersoll Rand remains in a strong financial position with liquidity of $3.8 billion. The Company generated $355 million of cash flow from operating activities and invested $29 million in capital expenditures, resulting in free cash flow1 of $326 million, compared to cash flow from operating activities of $404 million and free cash flow1 of $374 million in the prior year period. Year-to-date, free cash flow1 is approximately flat year-over-year. Net debt-to-Adjusted EBITDA leverage2 was 1.8x for the third quarter, which was an increase of 0.1x as compared to the third quarter of the prior year.
    
    
      Consistent with our comprehensive capital allocation strategy, in the third quarter of 2025, Ingersoll Rand deployed $249 million to M&A. Ingersoll Rand also closed on Dave Barry Plastics, a leading manufacturer of custom clean room solutions in August.
    
    
      The Company also returned $201 million to shareholders through $193 million in share repurchases and $8 million through its quarterly dividend payment in the third quarter.
    
    
      2025 Guidance3,4,5,6
    
    
      Ingersoll Rand is adjusting its guidance for full-year 2025 Adjusted EBITDA and Adjusted EPS ranges as outlined below.
    
    
      
        
          |  |  |  |  |  |  | 
        
          | Revised Guidance as of 10/30/25 | Key Metrics | 
        
          | 
              Revenue - Total Ingersoll Rand3
             | 4-6% | 
        
          | 
              Ingersoll Rand (Organic)4
             | (2)-0% | 
        
          | 
              Industrial Technologies & Services (Organic)
             | (2)-0% | 
        
          | 
              Precision & Science Technologies (Organic)
             | (2)-0% | 
        
          | 
              FX Impact5
             | ~1% | 
        
          | 
              M&A6
             | ~$415M | 
        
          | 
              Corporate Costs
             | (~$140M) | 
        
          | 
              Adjusted EBITDA4
             | 
              $2,060M - $2,090M (+2% - +4% YoY)
             | 
        
          | 
              Adjusted EPS4
             | 
              $3.25 - $3.31 ((1%) - +1% YoY)
             | 
      
     
    
      Reconciliations of non-GAAP measures related to full-year 2025 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
    
    
      Conference Call
    
    
      Ingersoll Rand will host a live earnings conference call to discuss the third quarter results on Friday, October 31, 2025 at 8:00 a.m. (Eastern Time). To participate in the call, please dial 1-888-330-3073, domestically, or 1-646-960-0683, internationally,
    
    
      2 Calculated as Net Debt to LTM Adjusted EBITDA
    
    
      3 All revenue outlook commentary expressed in percentages and based on growth as compared to 2024
    
    
      4 Non-GAAP measure (definitions and/or reconciliations in tables below)
    
    
      5 Based on September 2025 FX rates; does not include impact of FX on M&A
    
    
      6 Reflects all completed and closed M&A transactions as of October 30, 2025
    
    
      2
    
    
    
      and use access Code 8970061. A real-time audio webcast of the presentation can be accessed via the Events and Presentations section of the Ingersoll Rand Investor Relations website (https://investors.irco.com), where related materials will be posted prior to the conference call. A replay of the webcast will be available after conclusion of the conference and can be accessed on the Ingersoll Rand Investor Relations website.